Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07468552) titled 'Trial of Tirzepatide for the Treatment of Cannabis Use Disorder' on March 5.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: National Institute on Drug Abuse (NIDA)
Condition:
Cannabis Use Disorder
Intervention:
Drug: Tirzepatide
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: November 15, 2026
Target Sample Size: 100
To know more, visit https://clinicaltrials.gov/study/NCT07468552
Published by HT Digital Con...